Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Evidence of First Line Treatment With Arsenic Trioxide Plus All Trans Retinoic Acid in Adult Patients With Acute Promyelocytic Leukemia

NCT04897490 is registered in ClinicalTrials.gov with Grupo Argentino de Tratamiento de la Leucemia Aguda as lead sponsor.

NCT NCT04897490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04897490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Evidence of First Line Treatment With Arsenic Trioxide Plus All Trans Retinoic Acid in Adult Patients With Acute Promyelocytic Leukemia
Lead sponsor
Grupo Argentino de Tratamiento de la Leucemia Aguda
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2021
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

promyelocytic leukemia, adult acute